IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval

IM Cannabis Corp. IMCC IMCC  announced on Monday that it has received approval from the Israeli Ministry of Health to import premium, indoor-grown medical cannabis from Trichome JWC Acquisition Corp., its wholly-owned Canadian licensed producer that cultivates and sells the popular WAGNERS brand in the Canadian recreational market.

The company said the permit allows Focus Medical to import an initial shipment of premium medical cannabis in a quantity according to its terms.

“We are excited that Focus Medical has received approval from the MOH to import TJAC’s premium, indoor-grown dried flower, allowing for the launch of the WAGNERS brand in Israel,” Oren Shuster, CEO of IM Cannabis said. “This launch underscores the importance of IM Cannabis’ vertically integrated, multi-country strategy.”

The initial shipment is expected in the coming weeks and is subject to TJAC’s receipt of an export permit from Health Canada.

In addition, Focus Medical expects to import roughly 1,200 kilograms of premium cannabis from TJAC over the course of next year, as well as strains from other licensed producers such as the Flowr Group Inc.

Focus Medical will then sell the imported medical cannabis from IMC Canada’s TJAC facility to Israeli medical cannabis patients under the WAGNERS brand, the company’s popular Canadian recreational cannabis brand.

“By leveraging IMC Canada’s cultivation hub, our supply chain expertise, and our knowledge of the demands from medical cannabis patients and recreational cannabis consumers in various markets around the world, we will soon be able to provide Israeli medical cannabis patients with the premium quality indoor-grown cannabis that they demand,” Shuster added.

More recent news from IM Cannabis:

IM Cannabis Q3 Revenue Grows 30% Sequentially To $11.5M

IM Cannabis Reports 192% YoY Spike In Q2 2021 Revenue, Purchases Stake In Vironna Pharm

IM Cannabis Doubles Down On Israeli Cannabis Market With Two Acquisitions For $3.7M

IMCC Price Action

IM Cannabis’ shares traded 1.6348% lower at $4.0133 per share at the time of writing on Tuesday morning.

Photo: Courtesy of IM Cannabis Corp.

Posted In: israelOren ShusterWAGNERSCannabisNewsPenny StocksMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.